ATE394503T1 - Pathogene determinanten als zielmoleküle zur entwicklung von mitteln welche bakterielle infektionen und/oder systemische verbreitung verhindern und kontrollieren können - Google Patents

Pathogene determinanten als zielmoleküle zur entwicklung von mitteln welche bakterielle infektionen und/oder systemische verbreitung verhindern und kontrollieren können

Info

Publication number
ATE394503T1
ATE394503T1 AT03762684T AT03762684T ATE394503T1 AT E394503 T1 ATE394503 T1 AT E394503T1 AT 03762684 T AT03762684 T AT 03762684T AT 03762684 T AT03762684 T AT 03762684T AT E394503 T1 ATE394503 T1 AT E394503T1
Authority
AT
Austria
Prior art keywords
prevent
target molecules
bacterial infections
developing agents
serum
Prior art date
Application number
AT03762684T
Other languages
English (en)
Inventor
Sonia Escaich
Original Assignee
Mutabilis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mutabilis filed Critical Mutabilis
Application granted granted Critical
Publication of ATE394503T1 publication Critical patent/ATE394503T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT03762684T 2002-07-09 2003-07-09 Pathogene determinanten als zielmoleküle zur entwicklung von mitteln welche bakterielle infektionen und/oder systemische verbreitung verhindern und kontrollieren können ATE394503T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0208636A FR2842210B1 (fr) 2002-07-09 2002-07-09 Determinants de pathogenicite utilisables comme cibles pour l'elaboration de moyens de prevention et de controle d'infections bacteriennes et/ou de la dissemination systemique

Publications (1)

Publication Number Publication Date
ATE394503T1 true ATE394503T1 (de) 2008-05-15

Family

ID=29763685

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03762684T ATE394503T1 (de) 2002-07-09 2003-07-09 Pathogene determinanten als zielmoleküle zur entwicklung von mitteln welche bakterielle infektionen und/oder systemische verbreitung verhindern und kontrollieren können

Country Status (11)

Country Link
US (3) US20060003393A1 (de)
EP (1) EP1523572B1 (de)
JP (1) JP2006515155A (de)
AT (1) ATE394503T1 (de)
AU (2) AU2003266246A1 (de)
CA (1) CA2491847A1 (de)
DE (1) DE60320797D1 (de)
DK (1) DK1523572T3 (de)
ES (1) ES2306891T3 (de)
FR (1) FR2842210B1 (de)
WO (1) WO2004005535A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2842210B1 (fr) * 2002-07-09 2012-12-14 Mutabilis Determinants de pathogenicite utilisables comme cibles pour l'elaboration de moyens de prevention et de controle d'infections bacteriennes et/ou de la dissemination systemique
EP1567868A4 (de) * 2002-12-02 2008-02-06 Biosynexus Inc ZELLWAND-TEICHONSûURE ALS ZIEL F RANTI-STAPHYLOCOCCUS-THERAPIEN UND -IMPFSTOFFE
AU2006214064B2 (en) 2005-02-18 2012-04-26 J. Craig Venter Institute, Inc. Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
JP2008530245A (ja) 2005-02-18 2008-08-07 ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド 尿路病原性菌株由来の抗原
CN101370426A (zh) * 2006-01-20 2009-02-18 通用医疗公司 利用对光学相干断层扫描的波阵面调制来提供散斑减少的系统、装置和过程
EP2586790A3 (de) 2006-08-16 2013-08-14 Novartis AG Immunogene von uropathogenen Escherichia coli
CA2768343A1 (en) 2009-07-16 2011-01-20 Novartis Ag Detoxified escherichia coli immunogens
AU2017257851A1 (en) * 2016-04-25 2018-11-15 Aperture Bio, LLC Systems, devices and methods for sequential analysis of complex matrix samples for high confidence bacterial detection and drug susceptibility prediction using a flow cytometer
JP7515092B2 (ja) * 2017-10-18 2024-07-12 北海道公立大学法人 札幌医科大学 抗菌剤のスクリーニング方法
EP4272831A3 (de) 2018-08-09 2024-02-21 Antabio SAS Diazabicyclooctanones als inhibitoren von serin-beta-lactamasen
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases
CN115725607B (zh) * 2022-07-14 2023-11-28 山东第一医科大学附属省立医院(山东省立医院) 一种鼻疽诺卡菌的致病靶基因及其应用
CN118290546A (zh) * 2024-04-19 2024-07-05 三亚中国农业科学院国家南繁研究院 VdSti1蛋白或其编码基因在调控微生物致病力中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020121A (en) * 1995-09-29 2000-02-01 Microcide Pharmaceuticals, Inc. Inhibitors of regulatory pathways
WO1999066049A2 (en) * 1998-06-12 1999-12-23 University Of Guelph A novel gene and method of treating a gram negative bacterial infection
BR9915165A (pt) * 1998-11-09 2001-12-04 Microscience Ltd Genes e proteìnas de virulência e uso dos mesmos
JP2002535007A (ja) * 1999-01-27 2002-10-22 エリトラ ファーマシューティカルズ，インコーポレイテッド Ｅｓｃｈｅｒｉｃｈｉａｃｏｌｉの増殖に必要であると同定された遺伝子
FR2842210B1 (fr) * 2002-07-09 2012-12-14 Mutabilis Determinants de pathogenicite utilisables comme cibles pour l'elaboration de moyens de prevention et de controle d'infections bacteriennes et/ou de la dissemination systemique

Also Published As

Publication number Publication date
JP2006515155A (ja) 2006-05-25
CA2491847A1 (en) 2004-01-15
WO2004005535A3 (en) 2004-11-18
US20070111229A1 (en) 2007-05-17
WO2004005535A2 (en) 2004-01-15
DK1523572T3 (da) 2008-09-08
FR2842210A1 (fr) 2004-01-16
US20060003393A1 (en) 2006-01-05
ES2306891T3 (es) 2008-11-16
FR2842210B1 (fr) 2012-12-14
DE60320797D1 (de) 2008-06-19
AU2003266246A1 (en) 2004-01-23
AU2009201727A1 (en) 2009-05-21
HK1078902A1 (en) 2006-03-24
EP1523572A2 (de) 2005-04-20
US20110236886A1 (en) 2011-09-29
EP1523572B1 (de) 2008-05-07

Similar Documents

Publication Publication Date Title
Connolly et al. The host metabolite D-serine contributes to bacterial niche specificity through gene selection
Xiao et al. Isolation and identification of fish pathogen Edwardsiella tarda from mariculture in China
Arciola et al. Presence of icaA and icaD genes and slime production in a collection of staphylococcal strains from catheter-associated infections
Vasudevan et al. Phenotypic and genotypic characterization of bovine mastitis isolates of Staphylococcus aureus for biofilm formation
Li et al. The global regulon sarA regulates β-lactam antibiotic resistance in methicillin-resistant Staphylococcus aureus in vitro and in endovascular infections
Damron et al. Dual-seq transcriptomics reveals the battle for iron during Pseudomonas aeruginosa acute murine pneumonia
DE60320797D1 (de) Pathogene determinanten als zielmoleküle zur entwicklung von mitteln welche bakterielle infektionen und/oder systemische verbreitung verhindern und kontrollieren können
Kröber et al. Comparative transcriptome analysis of the biocontrol strain Bacillus amyloliquefaciens FZB42 as response to biofilm formation analyzed by RNA sequencing
Zhang et al. Interkingdom signal indole inhibits Pseudomonas aeruginosa persister cell waking
Kim et al. Improved multiplex PCR primers for rapid identification of coagulase-negative staphylococci
Dulla et al. Acyl-homoserine lactone-mediated cross talk among epiphytic bacteria modulates behavior of Pseudomonas syringae on leaves
CY1116385T1 (el) Αντινοηματικη διαμορφωση της εκφρασης της απολιποπρωτεινης β
Ostria-Hernández et al. Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae
Handley et al. PerR controls oxidative stress defence and aerotolerance but not motility-associated phenotypes of Campylobacter jejuni
Savage et al. Population diversification in Staphylococcus aureus biofilms may promote dissemination and persistence
ATE480247T1 (de) Immunstimulierendes mittel enthaltend eine biomasse von methanotrophem bakterium
Besse et al. Pseudomonas aeruginosa strains from both clinical and environmental origins readily adopt a stable small-colony-variant phenotype resulting from single mutations in c-di-GMP pathways
Wang et al. Changes in diversity of cultured bacteria resistant to erythromycin and tetracycline in swine manure during simulated composting and lagoon storage
Perichon et al. Glycopeptide-resistant Enterococcus faecium BM4416 is a VanD-type strain with an impaired D-alanine: D-alanine ligase
Kalai et al. Multidrug resistant staphylococci isolated from pigs with exudative epidermitis in North eastern Region of India
Donvito et al. Distribution of the synergistic haemolysin genes hld and slush with respect to agr in human staphylococci
Waite et al. Preliminary investigations into possible resistance to oxytetracycline in Melissococcus plutonius, a pathogen of honeybee larvae
Rom et al. The impacts of msaABCR on sarA-associated phenotypes are different in divergent clinical isolates of Staphylococcus aureus
Moche et al. Time-resolved analysis of cytosolic and surface-associated proteins of Staphylococcus aureus HG001 under planktonic and biofilm conditions
Zhang et al. Genome sequence of the banana pathogen Dickeya zeae strain MS1, which causes bacterial soft rot

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1523572

Country of ref document: EP

EEIH Change in the person of patent owner